Catheter Precision, Inc.

NYSEAM:VTAK Stock Report

Market Cap: US$1.2m

Catheter Precision Future Growth

Future criteria checks 2/6

Catheter Precision is forecast to grow earnings and revenue by 22.5% and 116.5% per annum respectively while EPS is expected to grow by 102.2% per annum.

Key information

22.5%

Earnings growth rate

102.2%

EPS growth rate

Medical Equipment earnings growth17.1%
Revenue growth rate116.5%
Future return on equityn/a
Analyst coverage

Low

Last updated12 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

NYSEAM:VTAK - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202610-6N/AN/A1
12/31/20254-9N/A-81
12/31/20241-9N/A-101
9/30/20240-12-8-8N/A
6/30/20240-9-7-7N/A
3/31/20240-7-11-11N/A
12/31/20230-71-21-21N/A
9/30/20230-78-22-22N/A
6/30/20230-82-25-25N/A
3/31/20230-89-26-26N/A
12/31/20220-27-23-23N/A
9/30/20220-27-25-25N/A
6/30/20220-30-28-28N/A
3/31/20220-26-28-28N/A
12/31/20210-27-28-28N/A
9/30/20210-29N/AN/AN/A
6/30/2021-2-29N/AN/AN/A
3/31/2021-1-34N/AN/AN/A
12/31/20200-35-28-28N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: VTAK is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: VTAK is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: VTAK is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: VTAK's revenue (116.5% per year) is forecast to grow faster than the US market (9% per year).

High Growth Revenue: VTAK's revenue (116.5% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if VTAK's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y